The Netherlands has observed a 21.80 million (5.2%) increase in the research & development by business enterprise, pharmaceutical industry in current ppp $, which now stands at 440.35 million.
Research & development by business enterprise, pharmaceutical industry in current PPP $ in the Netherlands
No matching regions
Similar regions to the Netherlands
Business R&D pharmaceutical in current PPP $
More indicators for the Netherlands
Government R&D in security as % of government support
2.6%
+1%
(2021)
Higher-education-finacing R&D financed by general university in local currency
14,230.55M
-517.31M
(1998)
R&D financed by rest of the world in local currency
20,403.43M
+1,253.43M
(2021)
Government R&D financed by rest of the world in local currency
1,114.90M
-165.10M
(2021)
Business R&D financed by rest of the world in local currency
14,598.52M
+1,358.52M
(2021)
Non-profit R&D growth rate
-15.42%
-18.68%
(2002)
Netherlands Business R&D pharmaceutical in current PPP $ between 2013 and 2021
| Period | Business R&D pharmaceutical in current PPP $ | Change |
|---|---|---|
| 2021 | 440.35M | +21.80M |
| 2020 | 418.55M | +74.49M |
| 2019 | 344.05M | +14.47M |
| 2018 | 329.58M | -33.52M |
| 2017 | 363.10M | +45.04M |
| 2016 | 318.06M | -14.05M |
| 2015 | 332.11M | +4.46M |
| 2014 | 327.65M | -33.18M |
| 2013 | 360.83M |